What is the study about? HER2-RADiCAL is investigating whether some people with HER2 positive breast cancer can safely receive less treatment after surgery. HER2 is a protein which can cause cancer to ...

Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...

HER2 mutations involve genetic alterations, while HER2 expression refers to protein overexpression, both impacting NSCLC treatment strategies. Fam-trastuzumab deruxtecan-nxki and ado-trastuzumab ...

9月13至17日，欧洲肿瘤内科学会（ESMO）年会在西班牙巴塞罗那盛大召开。会上，众多专家学者竞相展示肿瘤学领域的最新研究成果，共同推动肿瘤学科的全球发展。多项来自中国学者的学术成果在本次大会首次亮相，其中，由北京大学肿瘤医院沈琳教授担任主要 ...

Here’s what you need to know about your HER2+ breast cancer diagnosis so you can take your first steps to plan your treatment and get support.

Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...

Check out our click-worthy advice on buying mice for work or play, plus thorough reviews of the newest models. I’m an Analyst and ISF-certified TV calibrator focused on reviewing computer ...

Celia Ford is a Future Perfect Fellow focusing on the intersection of emerging technology, culture, and the mind. She is also fascinated by the process of science, the institutions that fund it ...

The EMA has started a review of AstraZeneca and Daiichi Sankyo's antibody-drug conjugate (ADC) that could see the drug being used in advanced breast cancer with even lower levels of the HER2 ...

Mixed and mature deciduous forest with sparse ground cover harbor the largest populations. Deer mice construct spherical or cup-shaped nests of shredded plant fibers, fur, and feathers under logs, ...

BARCELONA, Spain — Trastuzumab deruxtecan (TDXd) shows promise as a treatment for HER2-low and HER2-ultralow hormone receptor (HR)–positive metastatic breast cancer, according to data from the ...